Meeting
2018 ASCO Annual Meeting
Prognostic benefit of taking statin and/or metformin in elderly patients with advanced non-small cell lung cancer: A nationwide population-based epidemiologic study.
Authors
Yun-Gyoo Lee
Division of Hematology/Oncology, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea
Yun-Gyoo Lee , Ju Hyun Lee , Joung Soon Jang , Jee Hyun Kim
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Patient and Survivor Care
Track
Patient and Survivor Care
Sub Track
Geriatric Oncology
Citation
J Clin Oncol 36, 2018 (suppl; abstr 10045)
DOI
10.1200/JCO.2018.36.15_suppl.10045
Abstract #
10045
Poster Bd #
33
Abstract Disclosures
Similar Posters
Poster
2019 ASCO Annual Meeting
Determinants of early discontinuation of first-line chemotherapy, and associated outcomes among elderly with advanced non-small cell lung cancer.
First Author: Pramit Nadpara
Poster
2019 ASCO Annual Meeting
Cost disparities with age in the treatment of advanced non-small cell lung cancer (NSCLC) in Ontario, Canada.
First Author: Ying Wang
Poster
2013 ASCO Annual Meeting
The impact of diabetes mellitus and metformin on survival of patients with advanced pancreatic cancer receiving chemotherapy.
First Author: Do-Youn Oh
Poster
2024 ASCO Annual Meeting
A phase 2/3 study of fianlimab, cemiplimab, plus chemotherapy versus cemiplimab plus chemotherapy in first-line treatment of advanced non-small cell lung cancer.
First Author: Nashat Gabrail